Fourier Intelligence Inks Master Research Collaboration with TTSH CART

Technology unicorn Fourier Intelligence is furthering its global expansion and ambition to bring life-changing rehab robotics to more people around the world through its latest strategic partnership with Tan Tock Seng Hospital in Singapore.

Fourier Intelligence has signed a Master Research Collaboration with TTSH’s Clinic for Advanced Rehabilitation Therapeutics (CART), which is marking a decade of pioneering innovation and empowering patients through its work in neurorehabilitation.

The three-year collaboration will focus on the co-development of sustainable care models to help improve patients’ access to robotic therapies in both outpatient and community settings, beyond traditional specialist hospital rehabilitation.

CART – which is marking its anniversary through a move into new premises, four times the size of its previous clinic – incorporates Fourier Intelligence’s RehabHub™, a forum for its range of state-of-the-art robotics to combine to support patient recovery and maximise rehabilitation potential, with the new partnership offering even greater possibilities for patient outcomes.

The research will involve the ArmMotus™ EMU upper body robot, winner of this year’s Red Dot Design Award and iF Award, which has been hailed as having the potential to redefine neurorehabilitation through its pioneering design and capability.

Through its expertise in using robotics – CART is the region’s first clinic to integrate robotics and virtual reality (VR) with traditional therapies – the clinic will be a ‘living lab’ to test and accelerate the adoption of Fourier Intelligence’s near market-ready innovations.

One innovation currently being studied is the pioneering BalanceMotus™, which incorporates game-based features to enable therapists to measure patients’ balance and fall risk digitally and in precision within 20 minutes, instead of the longer manual scoring. CART is evaluating the potential for more enhanced features to be developed to widen its potential into new patient groups, including the elderly.

The partnership will also explore the potential use of such robotic technologies in the premises of TTSH’s community care partners and telerehabilitation therapy in patients’ homes, maximising the chances of patient engagement and participation.

It builds further on Fourier Intelligence’s approach to strategic partnerships and collaboration with key sites around the world, including the University of Melbourne and the Shirley Ryan AbilityLab in Chicago, to deliver world-leading rehabilitation robotics to patients around the world.

The Master Research Collaboration was confirmed through an official signing ceremony attended by Zen Koh, Fourier Intelligence Co-founder and Group Deputy CEO, and Professor Eugene Fidelis Soh, CEO of TTSH & Central Health.

The event also included CART’s additional new partnership with Stroke Support Station, a stroke-focused community rehabilitation agency with expertise in robotic aided rehabilitation, the potential for rehab to be delivered outside of traditional hospital settings in Singapore increases further still.

The opening ceremony of the new CART and its strategic partnerships was officiated by Minister for Health, Mr Ong Ye Kung.

“We are honoured to deepen our collaboration with CART, the largest hospital facility in Singapore,” says Zen Koh.

“Working together, we can consolidate our resources and jointly develop and test meaningful next generation technologies for use by clinicians and patients, which will maximise patients’ recovery potential and enable us to bring these innovations to more people than ever before.”

“CART has been relentless in its pursuit of revolutionising patient care from the hospital to the community and home,” says Dr Loh Yong Joo, Head, Rehabilitation Medicine, Integrative & Community Care, TTSH.

“It has embraced new technologies and combined them with conventional treatment approaches in seeking the best possible outcomes for patients.”

“Its strategic partnerships with leading industry players, academics and community partners have contributed significantly to its remarkable growth and achievements in its first 10 years.”

“We look forward to a dynamic partnership with Fourier Intelligence to bring the best rehabilitative care for our patients.”

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com

Logo MOU white BG Create Change

Fourier Intelligence Inks Industry-Academic Partnership with The University of Queensland

The public research university forges an agreement with the SoftBank-backed rehab robotics leader, Fourier Intelligence

SINGAPORE, April 11, 2022 – Fourier Intelligence announces its partnership with The University of Queensland (UQ). The partnership was inked to deliver research for personalised robotic therapy for restoration of walking function after stroke combining Fourier Intelligence’s EXOPS™, and UQ’s expertise in Neuroengineering, Rehabilitation, Medical Robotics, and Artificial Intelligence.

The project, led by Dr Alejandro Melendez-Calderon (UQ), involves a transdisciplinary research team of Biomedical and Rehabilitation Engineers, Scientists, and Clinicians across multiple faculties and institutes and aims at co-developing robot-assisted methods for promoting recovery, suited to the Australian healthcare system.

A virtual signing was held on the 6th of April 2022 to commemorate the partnership between Fourier Intelligence and UQ. The virtual signing ceremony was attended by Zen Koh, Co-Founder and Group Deputy CEO, CEO of Global HQ, Owen Teoh, General Manager, Sarah Lim, Assistant Director of Support Services, Taya Hamilton, Clinical Consultant, Oceanic Region, Chen Onn Leong, Manager for Scientific Research from Fourier Intelligence; Prof. Denny Oetomo, co-director of the University of Melbourne & Fourier Robotics Laboratory; and Lisa Kennedy, Director of Research Partnerships, and Dr Alejandro Melendez-Calderon, Principal Investigator, from The University of Queensland.

Top from left: Owen Teoh, Zen Koh, Lisa Kennedy, Prof Denny Oetomo
Bottom from left: Chen Onn Leong, Sarah Lim, Dr Alejandro Melendez-Calderon, Taya Hamilton

With this partnership, The University of Queensland will become part of the Global Rehabilitation & Assistive Technology (GReAT) Network – an international association between top academic and clinical institutions around the world to optimise resource sharing and knowledge transfer in assistive and rehabilitation technologies. The goal is to facilitate the efforts of engineers, academics, and clinical stakeholders focused on translational research from early research and development stages into clinical adoption.

The team is leveraging capabilities created by the UQ Artificial Intelligence (AI) Collaboratory Initiative and Fourier Intelligence’s unique  EXOPS™ platform combined with the company’s comprehensive rehabilitation solutions portfolio.

Fourier has developed its very own intelligent healthcare robotics technology platform, RehabHub™, to provide tailored digital healthcare solutions that will revolutionise the neurorehabilitation industry. Using Fourier Intelligence’s RehabHub™ technology and the EXOPS™ platform, UQ and other research groups around the globe are working to ensure advanced technologies provide meaningful, individualised, and effective therapy that is widely applicable and enhances the quality of life of patients worldwide.

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com

Fourier Intelligence’s ArmMotus™ EMU Wins ‘Red Dot Design Award’

The SoftBank-funded robotics leader Fourier Intelligence announces their accolade for the 3D upper limb rehabilitation robot from one of the most sought-after industrial design awards, also known as the “Oscar” of the sector

SHANGHAI, April 6, 2022 – Fourier Intelligence announces its Red Dot Design accolade for its 3D upper limb rehabilitation robot, the ArmMotus™ EMU. The device was evaluated by over 50 experts, including independent designers, design professors, and industry media partners based on the merits of its ergonomic design, aesthetics, and product functionality.

The ArmMotus™ EMU is the world’s first 3D back-drivable upper limb rehabilitation robot, setting a new benchmark for intelligent rehabilitation devices. With it being a multifunctional, immersive, end-effector based 3D upper limb rehabilitation robot, the ArmMotus™ EMU brings a whole new experience of robotics rehabilitation therapy to the world.

The design of the ArmMotus™ EMU has redefined the human-machine interaction. It is the first of its kind that applies the end-effector based concept to  3D movements, which makes it multifunctional and transparent. This transparency starts with a cable-driven mechanism, that combines with a 4-linkage structure, which perfectly reduces the friction and inertia during the movement of the system. This design also enables the control system to respond and execute more efficiently.

The device was made possible through industry-academic collaboration by research. The EMU was jointly built by Fourier Intelligence and the University of Melbourne Robotics Laboratory. After numerous studies and assessments from a simple wooden prototype, the ideal device was developed. The device was launched into the market back in September 2021 during the virtual RehabWeek 2021.

With its excellent R&D capabilities and its productivity at the helm of innovation, Fourier Industrial Design Centre was formerly awarded the 2021 Shanghai Design Innovation Centre whilst the ArmMotus™ EMU proved to be a world-leading masterpiece through recognition from its Red Dot Award.

Red Dot is one the most sought-after seals of quality for good design. Also known as the “Oscar” of the sector, the ‘Red Dot Design Award’ stands for its international design competition based on excellence in product designs and concepts by experts.

Aiming to provide a better life for the people through intelligent technology, Fourier Intelligence will continue to invest in research and development of robotic technology to deliver an end-to-end solution for various applications of robots.

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com

Fourier Intelligence Inks Strategic Alliance Partnership with MyndTec Inc.

The award-winning Canadian MyndMove™ therapy from MyndTec. Inc joins SoftBank-backed rehab robotics leader Fourier Intelligence’s network of partners

SINGAPORE, March 23rd, 2022 – Fourier Intelligence has announced a strategic alliance partnership with MyndTec Inc, an award-winning Canadian medical technology company specialising in innovative therapeutic medical devices.

This partnership will focus on the distribution of MyndMove™, a non-invasive functional electrical stimulation-based intervention, to the ever-expanding global network of Fourier Intelligence.

A virtual signing ceremony was held to commemorate the partnership between both parties. MyndTec’s CEO, Craig Leon, Co-Founder, Dr Milos R. Popovic, Fourier Intelligence Co-Founder and Global HQ CEO, Zen Koh, General Manager, Owen Teoh and Operations Director, Sandra Lee, attended the virtual event.

From top left: Mr Owen Teoh, General Manager, Fourier Intelligence, Dr Milos R. Popovic, Co-Founder MyndTec Inc., and Ms Sandra Lee, Operations Director, Fourier Intelligence.
From bottom left: Mr Craig Leon, CEO of MyndTec Inc. and Mr Zen Koh, Fourier Intelligence Global HQ CEO

This partnership is timely as both parties recently reached strategic milestones. Fourier Intelligence received a Series D growth investment led by the SoftBank Group and backed by the Saudi Aramco P7 Venture Fund and the Yuanjing Capital earlier this year. MyndTec met all the requirements of the Canadian Securities Exchange (CSE) and began trading its common shares on the CSE on February 24th under the ticker symbol MYTC.

“Our partnership with MyndTec Inc. signifies yet another successful strategic collaboration with market leaders to offer innovative and clinically effective technology for our patients globally,” said Zen Koh, Co-Founder and Global HQ CEO of Fourier Intelligence. “MyndMove™, an electrical stimulation-based intervention, integrates perfectly into Fourier’s RehabHub™ solution and complement our existing product/technology portfolio. Fourier will continue our investment into more of such joint technological developments to better provide highly integrated intelligent rehabilitation technologies to empower clinicians and patients.”

Fourier’s global network spans over 50 countries to ensure a broad market outreach for innovative technologies. With joint laboratories with some of the top research institutes in the world such as ETH Zürich, University of Melbourne, and Shirley Ryan AbilityLab in Chicago, Fourier is set to chart the new frontier of innovative medical technologies.

MyndMove™ therapy
RehabHubTM

“We are excited to enter into this meaningful partnership with Fourier Intelligence to strategically integrate our MyndMove™ technology into RehabHub™. Fourier’s proven track record establishing globally successful RehabHub™, positively changing patient lives globally and the addition of MyndTec’s innovative MyndMove™ therapy to this network will enable us to reach out to more patients worldwide,” said Craig Leon, CEO of MyndTec.

MyndTec’s medical devices are designed to improve function, maximise independence, and enhance the quality of life for individuals with upper limb paralysis due to stroke, spinal cord injury, or some cases of traumatic brain injury*.

MyndTec Inc. also partners with several organisations such as the KITE Research Institute, the research arm of the Toronto Rehabilitation Institute – University Health Network and the University of Toronto to develop and commercialise MyndMove™ therapy. The MyndMove™ therapy is also supported by numerous clinical studies, including randomised controlled trials in stroke and spinal cord injuries. The embedded stimulation protocols in MyndMove™ allows clinicians to stimulate natural, purposeful, and functional movements in patients.

*Disclaimer: MyndMove™ claims may differ depending on the jurisdiction. Please contact MyndTec for details.

Media Contact
MyndTec Inc.
Craig Leon
Email:  investor.relations@myndtec.com
(416) 569-0430

Fourier Intelligence
Grace NG
Senior Marketing Manager
Email: marketing.globalhq@fftai.com

BalanceMotus™ KINE-SIM – The world’s first balance and gait device of its kind

Zen Koh, Co-Founder and Global HQ CEO, Fourier Intelligence Group

Rehab-robotics leader Fourier Intelligence partners MedTech KINESIQ to launch BalanceMotus™ KINE-SIM as part of the RehabHub™ concept – the world’s first balance and gait exercise equipment combining motorised force plates with real-life scenarios dedicated to functional autonomy preservation.

Read more about the story here.

BalanceMotus™ KINE-SIM

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com

SoftBank-funded Fourier announced a strategic partnership with KINESIQ Inc.

The Canadian med-tech company, KINESIQ Inc. and SoftBank-funded Fourier Intelligence, the global leader in rehabilitation robotics, announces strategic partnership

Singapore, March 1, 2022 – Fourier Intelligence entered a bilateral strategic partnership with KINESIQ Inc. As part of the global partnership, KINESIQ and Fourier Intelligence will jointly launch the BalanceMotus™ KINE-SIM as part of the RehabHub™ concept globally in March 2022 in response to increasing demand for intelligent rehabilitation solutions.

BalanceMotus™ KINE-SIM

KINESIQ Inc. developed the BalanceMotus™ KINE-SIM, the world’s first balance and gait exercise equipment combining two motorised force plates with real-life scenarios dedicated to functional autonomy preservation in August 2021.

Fourier Intelligence’s RehabHub™

KINESIQ Inc. will fully integrate its technology into the Fourier Intelligence RehabHub™ Movement & Balance Series under this partnership. This comes timely as Fourier, which recently closed its Series D funding led by SoftBank Vision Fund 2 and followed by Prosperity7 Ventures, an Aramco Ventures Fund and Vision Plus Capital, is accelerating its innovation in healthcare robotics solutions and expansion of global market reach.

“KINESIQ Inc. is very excited to enter into this strategic partnership,” said Lukas Dufault, President and CEO of KINESIQ Inc. “Our partnership with Fourier enables us to focus on delivering innovative healthcare solutions. This strategic partnership allows both parties to leverage on each other’s strength and resources, to increase further our installation base riding on Fourier’s Global Sales and Marketing network covering more than 54 countries.”

Zen Koh, Co-Founder and Global HQ CEO, Fourier Intelligence Group

“Fourier is pleased to be part of this global shift towards consolidation of healthcare solutions companies. We firmly believe our domain-specific expertise will fuel more of such strategic collaborations that address the healthcare challenges we see today,” said Zen Koh, Co-Founder and Global HQ CEO of Fourier Intelligence Group. “Fourier will continue to invest in such partnerships to stay ahead of the competition, and we look forward to the next stage of our journey, together with our strategic partners.”

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com

MotusAcademy Presents Webinar Series with Top Rehabilitation Technology Industry Leaders

In just two days, MotusAcademy will be launching its first Thematic Webinar Series alongside some of the world’s foremost rehabilitation technology industry leaders. At 1600 Hrs (GMT +8) on 17th Feb 2022, MotusAcademy will kickstart the first of its four-part virtual seminar series.

The launch will be officiated by MotusAcademy’s President, Professor Robert Riener, from the Sensory-Motor Systems lab at the Department of Health Sciences and Technology, ETH Zurich. Professor Riener is also the founder and organiser of CYBATHLON – an international multi-sport event in which people with physical disabilities compete in carrying out daily tasks using state-of-the-art technical assistance systems.

The first webinar will take the form of a coffee chat with the speakers where audiences have the opportunity to join the speakers in sharing their journey, experience and insights revolving around the industry of rehabilitation. After the session, audiences will surely have a better grasp of the missions, visions and goals, as well as the challenges and barriers of the rehabilitation industry.

The webinar speaker line-up includes:

  • Zen Koh, Co-founder and Group Deputy CEO of Fourier Intelligence – one of the world’s prominent developers in rehabilitation robotics solutions and technology.
  • Gery Colombo, Healthcare and Technology Expert; Founding President (2011 – 2019) of International Industry Society in Advanced Rehabilitation Technology (IISART); Founder and Former CEO of Hocoma AG – global market leader in the development, manufacturing and marketing of robotic and sensor-based devices for functional movement therapy.
  • Alexander Kollreider, CTO and Founder of Tyromotion – one of the world’s leading manufacturers and suppliers of technology-based therapy.

Subsequent webinars will tap into in-depth topics of the rehabilitation industry, for example, hand robotics, limb robotics, balance technologies, telerehabilitation, functional electrical stimulation and augmented reality (AR). These sessions will also feature engineers, academics and clinicians to share real-life experiences in working with rehabilitation. Through the sharing sessions, audiences can appreciate the interrelationships between the different roles in the rehabilitation industry.

Unlike a typical one-hour webinar with only the speakers delivering their materials, MotusAcademy promises to present a discussion platform for all parties interested in rehabilitation technology. With that, audiences will be able to pose questions throughout the webinar session. Apart from getting on-the-spot first-hand responses from the experts, those questions will be utilised as perceptive references for the planning of future webinars.

About MotusAcademy

MotusAcademy is a dedicated platform for sharing knowledge in the field of advanced rehabilitation technology, including therapeutic robotics, assistive technologies and supporting technologies such as functional electrical stimulation and virtual reality. MotusAcademy is designed to support ongoing education and discussions between engineers, clinicians and researchers in the field of robotics technology. MotusAcademy’s affiliations include the IISART, CEN Academy and Masterclass in Neuro Technology (MiNT Concept) by Hobbs Rehabilitation.

Professor Robert Riener, President of MotusAcademy

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com

IISART’s Next Incoming President – Zen Koh

SINGAPORE, Feb 10, 2022 Zen Koh, Co-Founder and Group Deputy CEO of Fourier Intelligence, has been elected as the incoming President of The International Industry Society in Advanced Rehabilitation Technology (IISART) during the society’s most recent virtual General Assembly on 20th January 2022. The election was conducted amongst the key members of IISART through an anonymous voting poll.

As a leader in the rehabilitation field for 20 years, Zen has founded several MedTech companies. “I am honoured to have the support from the members of IISART. With my presidency in IISART, we can drive the rehabilitation industry forward through adaptation in technologies and innovation,” said Zen, who has been awarded by MD+DI as one of the Top 40 Under 40 Future Most Influential Leaders in MedTech.

Dr Martina Spiess
Co-President of IISART (2019 – 2021)
Research Associate, Zurich University of Applied Sciences

Dr Martina Spiess, the Co-President of IISART (2019 – 2021) and a Research Associate from Zurich University of Applied Sciences, has stated, “The steering committee of IISART acknowledges Zen’s support and contribution throughout these years; Zen is no doubt the ideal candidate for the President of IISART”.

Dr Iris Jakob, PhD
The 2nd Co-President of IISART (2019 – 2021)
Scientific Coordinator, Tyromotion

Dr Iris Jakob, the second Co-President of IISART (2019 – 2021) and a Scientific Coordinator of Tyromotion, has described, “Zen is certainly well-connected and has proven his successes in the rehabilitation field. With Zen spearheading IISART, he will be the drive for different companies to collaboratively work together with IISART to promote knowledge and raise the standards of advanced rehabilitation technology”.

Gery Colombo, PhD
Founding President of IISART (2011 – 2019)
Founder & Former CEO, Hocoma

Dr Gery Colombo, the founder and former CEO of Hocoma AG and Founding President of IISART, has expressed that with Zen’s leadership, there will be diversity where different perspectives are valued and sought. “Closing the gaps between a manufacturer’s pain point and a customer’s standpoint, while prioritising the patient’s need, is what the industry is hoping to improve; Zen can contribute and help expedite the process. Take the RehabWeek for instance, numerous delegates will be able to corroborate that Zen was able to bring more people with similar interests together”.

“It is great and exciting to see how IISART is developing. With the seven new members, the society will become even stronger! Thank you to all the steering members for keeping this important mission going so well”, concluded Dr Gery Colombo at the end of the General Assembly.

IISART represents the interests of developers, manufacturers and marketers of medical devices with their products and services in Robotics, Virtual Rehabilitation and Therapeutic Electrical Stimulation. IISART strives to shape the future of rehabilitation with the collective efforts of its central panel members. For more information, please visit https://iisart.org/

Zen Koh, with ExoMotus™, the next-gen robots

For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhq@fftai.com

Fourier Intelligence Closed RMB 400 Million in Series D Funding from SoftBank Vision Fund 2

The new funding will accelerate market expansion, enable innovation across its advanced healthcare robotics solutions and accelerate global growth opportunities

SINGAPORE, January 26, 2022 – Fourier Intelligence, a Shanghai-based medical technology company, received a growth investment of RMB 400 million in Series D Funding, led by SoftBank Vision Fund 2 and backed by Saudi Aramco P7 Venture Fund and the Yuanjing Vision Plus Capital. The new funding will accelerate Fourier’s go-to-market expansion, enable innovation across its advanced healthcare robotics solutions and accelerate global growth opportunities.

Led by Alex Gu, Founder and Group CEO, and Zen Koh, Co-Founder and Group Deputy CEO, Fourier Intelligence is a global leader in Neurorehabilitation Robotics, Artificial Intelligence (AI) and digital rehabilitation solutions for the healthcare industry. Leveraging intelligent robotics, smart actuators, sensors, machine learning, and proprietary control algorithms, Fourier develops and provides an intelligent healthcare robotic platform, RehabHub™, that delivers tailored digital healthcare solutions that revolutionise the neurorehabilitation industry. The company has 1,000+ global institutional healthcare customers and 17 international research joint labs in Singapore, Chicago, Phoenix, Zürich, Melbourne, Madrid, Kobe, and Kuala Lumpur.

Fourier focused on delivering widespread patient access to technology-enabled therapies. We achieve this with our intelligent robotic solution, RehabHub™, which is effective and affordable.

— Zen Koh, Co-founder & Group Deputy CEO

 “The rehabilitation market has significant tech adoption potential, and we grew our revenue close to over 3 times in 2021, despite the challenges posed by the global pandemic.”, said Alex Gu, Founder and Group CEO of Fourier Intelligence. “China sees increasing demand for rehabilitation services with the ageing population, increased number of patients with chronic diseases, and rehab development in the clinics. There has been a continuous shortage of physicians nationwide. In addition, Fourier’s comprehensive product portfolio with solid capabilities in hardware (including force sensor, monitor, and controller) and algorithm (for force control and feedback) is well-positioned to address clinical pain points. We believe intelligent rehabilitation technology companies like Fourier Intelligence can solve the talent bottleneck and provide practical and quantifiable treatments to improve patient outcomes. We are pleased to partner with Joanne Xu and the SoftBank Investment Advisers team to continue our development of the intelligent rehabilitation sector. We look forward to harnessing their support to create significant value not only for the medical rehabilitation robotic communities but also for the robotic world to tackle the most complex global challenges facing humanity and the environment.”

As a global leading manufacturer and solutions provider of AI-powered rehabilitation robotics, Fourier is committed to technological innovation and has been leading, supporting, and participating in international scientific research in the field of rehabilitation robotics. Some of such initiatives are joint research laboratories, respectively, with the Shirley Ryan AbilityLab (formerly known as the Rehabilitation Institute of Chicago) in the United States, the University of Melbourne in Australia, ETH Zürich in Switzerland, National University of Singapore, Kobe University in Japan and the KITE Research Institute at the Toronto Rehabilitation Institute in Canada. These partnerships put Fourier at the forefront of technological innovation and enable Fourier to offer industry-leading products across end-to-end rehabilitation services, with innovative solutions to solve specific clinical constraints.

Influential Colossal Investment Institution Backs Unicorn-to-be Neurorehabilitation Robotic Company in Defining the Future of the Industry

“As China’s population ages, there is increasing demand for rehabilitation services, but these patients face a shortage of qualified therapists,” said Joanne Xu, Partner at SoftBank Investment Advisers. “We believe that Fourier Intelligence is well placed to solve this talent bottleneck by using technology to provide effective and quantifiable treatments to achieve better patient outcomes. It has built an integrated solution combining a digital platform, hospital services and a comprehensive product portfolio in collaboration with 30+ world-leading hospitals and research institutions. We are excited to partner with Alex Gu and the team to support technological innovation in China’s rehabilitation sector.”

Driven by its vision of ‘rehabilitation for all’ through intelligent technology, Fourier Intelligence implemented a series of modern rehabilitation centres with strategic institutional clinical partners under its RehabHub™ concept. The possibility of data interconnectivity and multi-machine coordination between multiple rehabilitation robotics reduced the number of clinicians required, significantly improving efficiency and costs. The company aims to become a global one-stop solution provider for intelligent rehabilitation whilst providing world-class technology that is affordable and highly competitive for the clinical market.

“Our mission as a company is to enable widespread patient access to life-changing technology-enabled therapies. One of the biggest obstacles to achieving this is the high costs and low technology adoption rate. Our team focused on the urgent need to enhance availability, accessibility, and affordability, yet ensuring the effectiveness of our intelligent robotic solution, RehabHub™,” added Zen Koh. “The significant experience and capital that our strategic investors bring to Fourier will help us rapidly realise global commercialisation and to deliver these innovative therapies to as many patients as quickly as possible.”

“Prosperity 7 is thrilled to continue supporting Fourier in this latest round of investment and through ongoing strategic collaboration,” said Aysar Tayeb, Executive Managing Director of P7. “We hope to land Fourier’s rehabilitation solutions within the Kingdom’s network of hospitals and clinics and look forward to working with the company to deliver the most advanced rehabilitation services and solutions and improve recovery and the quality of life for patients in Saudi Arabia and beyond.”


For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: marketing.globalhub@fftai.com

Fourier Intelligence Joins the IFR

IFR

Rehabilitation robotics pioneers, Fourier Intelligence, formally accepted as members of the International Federation of Robotics (IFR)

SINGAPORE, Jan 20, 2022Fourier Intelligence has been formally accepted as a member of the International Federation of Robotics (IFR), joining a group of well-acclaimed institutional members from the robotics industry and research and development institutes such as KUKA, Intel and Panasonic. Fourier Intelligence will also be the pioneering member to represent rehabilitation robotics in the IFR.

The IFR’s mission is to connect the world of robotics around the globe, with the aim of promoting the positive benefits of robotics for productivity, competitiveness, economic growth, and quality of work and life. This non-profit organisation also serves the purpose to promote research, development, use and international co-operation in the entire field of robotics.

“We are happy and very much looking forward to being part of the IFR,” said Zen Koh, Co-Founder and Global HQ CEO of Fourier Intelligence. “Being a member of this federation is a great privilege. This will allow us to have a platform to share information on the latest technology trends and exchange ideas with other top members in this. We are also excited to foster more alliances and partnerships with other members which we believe will be very beneficial to our company’s growth.”

Co-Founder and Global HQ CEO of Fourier Intelligence, Zen Koh

“Besides that, the vision of the federation also aligns perfectly with Fourier’s vision, which is to promote the positive benefits of robotics in various fields such as rehabilitation. As a pioneering member to represent rehabilitation robotics, we are very excited to advocate the adoption of robotics in rehabilitation worldwide.”

The IFR also works closely with the Institute of Electrical and Electronics Engineers (IEEE), the world’s largest technical professional organisation for electronic and electrical engineering. Since 2005, together with the IEEE, both has been co-sponsoring the IEEE/IFR Innovation and Entrepreneurship Award. The purpose of this award is to recognise the entrepreneurial commercialisation of ideas into actual products. The IFR and IEEE also jointly sponsors the IERA (Innovation and Entrepreneurship in Robotics and Automation) Award, which is to honor achievements of investors who propel value creating ideas into world-class products. Both the IFR and IEEE have a huge influence in the robotics industry.

Upon being accepted as a member of the IFR, Fourier Intelligence has plans to work closely together to release more white papers on rehabilitation robotics. Fourier Intelligence believes that together with the vast network of over 75 members of IFR from more than 20 countries, the awareness and adoption of rehab robotics can be more widely promoted globally.


For investor and media inquiries, please contact:
Grace Ng,
Senior Marketing Manager,
Fourier Intelligence
Phone: +6016-245-1585
Email: grace.ng@fftai.com